Phibro Animal Health | PAHC - Ordinary Share Capital


Phibro Animal Health reported $40.48M in Ordinary Share Capital for its fiscal quarter ending in December of 2025.





Ordinary Share Capital Change Date
Align Technology USD 71.62M 1000 Jun/2026
ANI Pharmaceuticals USD 22.49M 760K Dec/2025
Aurora Cannabis CAD 58.95M 2.24M Mar/2026
Bristol-Myers Squibb USD 2.04B 1.74B Sep/2025
Canopy Growth CAD 422.07M 53.78M Mar/2026
Corcept Therapeutics USD 107.33M 1.36M Mar/2026
Eli Lilly USD 943.5M 3.33M Mar/2026
Henry Schein USD 111.92M 2.51M Jun/2026
Idexx Laboratories USD 78.87M 366K Jun/2026
Knight Therapeutics CAD 99.68M 24.66K Sep/2025
Merck USD 2.47B 4.93M Mar/2026
Nektar Therapeutics USD 29.47M 9.09M Mar/2026
Pacira USD 39.82M 512K Jun/2026
Phibro Animal Health USD 40.48M 0 Dec/2025
Prestige Brands USD 47.37M 53K Jun/2026
Supernus Pharmaceuticals USD 58.16M 124K Jun/2026
Zoetis USD 414.15M 6.19M Jun/2026